Department of Pediatrics Archive — Page 49 of 54
-
December 9, 2013
Penicillin equally effective as ‘big gun’ antibiotics for treating less severe childhood pneumonia, Vanderbilt study shows
Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with “big gun” antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin. -
November 21, 2013
Ess named to take reins of Division of Pediatric Neurology
Kevin C. Ess, M.D., Ph.D., has been named chief of the Division of Pediatric Neurology within the Department of Pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
November 7, 2013
Guttentag named to direct Neonatology
Susan H. Guttentag, M.D., is joining Vanderbilt University on Feb. 1, 2014, as the new director of the Division of Neonatology within the Department of Pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. -
October 28, 2013
Tool predicts risk for developmental delays in early childhood
A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study. -
October 17, 2013
VUMC joins national stroke prevention research network
Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery. -
October 17, 2013
Fellow tracks post-vaccination bacterial trends
Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines. -
September 26, 2013
Vaccine Research Program lands major NIH renewal
The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.